Archive: 07/01/2015
Combined therapy can reduce chance of recurrence in women with small, HER2-positive breast tumors
In a phase 2 clinical trial, women with small (stage 1), HER2-positive breast tumors who received a combination of lower-intensity chemotherapy and a targeted drug following surgery were highly unlikely to have the cancer ...
Jan 7, 2015
FDA panel endorses first lower-cost biotech drug
Federal health experts have unanimously endorsed a Novartis drug which is expected to become the first lower-cost copy of a biotech drug to reach the U.S. market.
Jan 7, 2015
Physician survey indicates positive experience, desire for formal guidelines to improve peer review
Peer review is a common practice in medicine to support the complementary, multidisciplinary team approach in healthcare. A 2013 survey of radiation oncologists indicates that they would like more formal recommendations and ...
Jan 7, 2015
Synthetic oil drug may bring promise for Huntington's disease
An early study suggests that a synthetic triglyceride oil called triheptanoin may provide hope for people with Huntington's disease. The study is published in the January 7, 2015, online issue of Neurology, the medical journal ...
Jan 7, 2015
Type 2 diabetes risk varies with magnesium intake, genes and ethnicity
Magnesium is an important nutrient, in part because it appears to help regulate insulin secretion and/or action. Sure enough, studies over the last decade have shown that low intake of the mineral is a risk factor for developing ...
Jan 7, 2015